Novel cancer therapy blocks communication between cancer cells and cancer-associated fibroblasts
Retinitis pigmentosa cell therapy drug cleared for clinical trials in US and China
How cells fight back after bacterial toxins break through
New approach to treating chronic wounds
Pfizer injectable shows continued weight loss in phase 2b trial
Skin damage protein ID could lead to new therapies
Origami Therapeutics and Ipsen to advance protein degrader programme
IQVIA and Boehringer Ingelheim announce data collaboration
Next-generation biopreservation for cell therapy
Predicting cancer evolution
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion